
A potent third-generation macrolide antibiotic derivative used specifically in veterinary medicine to treat complex respiratory and enteric infections in livestock.
In the field of modern veterinary medicine, Acetylisovaleryltylosin Tartrate is recognized for its exceptional activity against Mycoplasma species and various Gram-positive bacteria. Zyntex provides this API with high biological potency, focusing on its ability to achieve rapid therapeutic concentrations in target tissues, particularly the lungs. Because of its unique molecular structure, it exhibits superior cellular penetration, making it an indispensable tool for managing complex respiratory syndromes in industrial livestock production.
Zyntex supplies Acetylisovaleryltylosin Tartrate in a highly refined, white to off-white powder form, optimized for high solubility and stable integration into premixes, oral solutions, or water-soluble formulations. Our stringent quality control measures ensure that the tartrate salt maintains its structural integrity and antimicrobial activity even under diverse environmental conditions. Furthermore, its excellent palatability ensures minimal interference with feed or water intake, supporting consistent dosing in large-scale animal husbandry.
From specialized veterinary research to large-scale pharmaceutical manufacturing, this versatile macrolide is a staple for modern animal health solutions. Its role in controlling Proliferative Enteropathy (Ileitis) and Swine Dysentery makes it a preferred choice for manufacturers focused on intestinal health. As a result, Zyntex acts as a dependable partner for the global agricultural sector. Finally, our commitment to high purity and rigorous batch testing helps your brand achieve international regulatory compliance and food safety standards effortlessly.
This professional-grade veterinary antibiotic delivers superior performance in the following sectors:
Essential API for treating Mycoplasma hyopneumoniae and porcine proliferative enteropathy (PPE).
Utilized in formulations for controlling chronic respiratory disease (CRD) caused by Mycoplasma gallisepticum.
Used as a primary active ingredient in the synthesis of water-soluble granules and injectable veterinary medicines.
Applied as a reference antimicrobial standard in laboratories focused on developing next-generation macrolide therapies.
| Parameter | Specification Standard |
|---|---|
| Product Name | Acetylisovaleryltylosin Tartrate |
| Grade | Veterinary Pharmaceutical Grade |
| Potency | Minimum 800 u/mg |
| Solubility | Freely soluble in water |
| CAS Number | 63096-86-8 |
🔬 Scientific Data: For detailed handling, antimicrobial spectra, and veterinary safety data, consult: PubChem Entry: Tylvalosin (External Link)